Teva Pharmaceutical Industries | TEVA - Gross Profit On Sales

Stock Price
9,337.00
Daily Change
-53.00 -0.56%
Monthly
2.55%
Yearly
70.23%
Q2 Forecast
8,997.46

Teva Pharmaceutical Industries reported $2.66B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Aspen Pharmacare ZAR 10.14B 830M Jun/2024
Cipla INR 41.64B 6.31B Dec/2025
Dr.Reddys Laboratories INR 51.37B 629M Dec/2025
Guangzhou Baiy CNY 1.7B 1.5B Dec/2025
Jiangsu Hengrui CNY 7.27B 918.27M Dec/2025
Kalbe Farma IDR 3.45T 151.13B Sep/2025
Richter Gedeon HUF 143.37B 25.78B Sep/2025
Sh Fosun Pharma CNY 4.8B 93.72M Sep/2025
Sun Pharmaceuticals INR 107.66B 2.05B Sep/2025
Teva Pharmaceutical Industries USD 2.66B 351M Dec/2025